Phase I trial of recombinant interleukin-2 and cyclophosphamide: augmentation of cellular immunity and T-cell mitogenic response with long-term administration of rIL-2.
暂无分享,去创建一个
J. Kolitz | K. Welte | V. J. Merluzzi | A. Engert | M. Konrad | E. Bradley | G. Y. Wong | T. Bialas | A. Polivka | C. Gnecco